Answers are grounded in this paper and cite their sources.
Introduction: Several studies have examined risk factors for COVID-19, and there have been conflicting results regarding whether blood type influences the risk of COVID-19. Therefore, this study aimed to determine the association between the ABO blood group system and the severity of COVID-19 in the West Bank of Palestine. Methods: A case-control study design was used, consisting of 169 cases and 169 controls who had undergone COVID-19 PCR testing in March 2021 in the West Bank, stratified according to their test results. A self-administered questionnaire in Arabic was used, which included the following parts: socio-demographic data, smoking status, seasonal flu, medical history of COVID-19, and the experience of COVID-19 cases. Both descriptive and analytical analyses were carried out. Binary logistic regression (Enter model) was used in the multivariate analysis to demonstrate the odds ratio. Results: The study included 338 participants (169 cases and 169 controls) with a 95% response rate. Among the participants, 46.4% lived in the northern region (Nablus, Jenin, Qalqilya, Salfit, Tubas, Tulkarm). Blood group B was found to be more protective against COVID-19 than blood group A (AOR=0.40, CI=0.223-0.718). Blood group AB was also more protective against COVID-19 than blood group A (P < 0.05, AOR=0.316, CI=0.143-0.698). There was no statistically significant difference between blood group A and blood group O concerning the severity of symptoms or the composite outcomes of COVID-19. Conclusion: There is an association between the ABO blood group and the risk of COVID-19. Nonetheless, the precise mechanism and severity of the effect vary, necessitating further investigation through larger and more intensively controlled studies.
No takes yet. Share an insight, caveat, or question.
Khdour et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: